June 19, 2007 - SenoRx Inc. announced that the U.S. Patent and Trademark Office has granted the company its third patent for the Multi-Lumen Radiation Balloon Applicator for the treatment of breast cancer, strengthening the current intellectual property for certain proprietary manufacturing and product design aspects of the Radiation Balloon.
The Radiation Balloon received 510(k) clearance in May for brachytherapy. SenoRx plans to market the Radiation Balloon for post-FDA clearance human clinical trials supporting marketing claims and to also host clinical education events in the second half of 2007. The Radiation Balloon product’s full launch is expected in early 2008.
For more information: www.senorx.com